Feedback activation of STAT3 in oncogene-addicted cancers has also been demonstrated with other targeted therapies, implicating a potential role of targeting these pathways more broadly in the genomic subtypes of lung cancer [19]. Here, STAT3 is linked to lung carcinoma.